These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18829682)

  • 1. MMP expression and abnormal lung permeability are important determinants of outcome in IPF.
    McKeown S; Richter AG; O'Kane C; McAuley DF; Thickett DR
    Eur Respir J; 2009 Jan; 33(1):77-84. PubMed ID: 18829682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
    Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
    Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change of matrix metalloproteinase-1 and matrix metalloproteinase-7 in serum and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and sarcoidosis].
    Zhou LF; Jiang L; Li ZH; Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):441-4. PubMed ID: 20979817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
    Craig VJ; Zhang L; Hagood JS; Owen CA
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the bronchoalveolar lavage fluid and the serum of patients with idiopathic pulmonary fibrosis].
    Wei LQ; Li ZH; Kang J; Hou XM; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):399-402. PubMed ID: 17045024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
    Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
    Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.
    Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J
    Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
    Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL
    APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort.
    Todd JL; Vinisko R; Liu Y; Neely ML; Overton R; Flaherty KR; Noth I; Newby LK; Lasky JA; Olman MA; Hesslinger C; Leonard TB; Palmer SM; Belperio JA;
    BMC Pulm Med; 2020 Mar; 20(1):64. PubMed ID: 32171287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?
    Huh JW; Kim DS; Oh YM; Shim TS; Lim CM; Lee SD; Koh Y; Kim WS; Kim WD; Kim KR
    Chest; 2008 May; 133(5):1101-6. PubMed ID: 18071010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.
    Nkyimbeng T; Ruppert C; Shiomi T; Dahal B; Lang G; Seeger W; Okada Y; D'Armiento J; Günther A
    PLoS One; 2013; 8(9):e73279. PubMed ID: 24023851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation.
    Krenn K; Klepetko W; Taghavi S; Paulus P; Aharinejad S
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):35-41. PubMed ID: 17481912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R; Tan BK; Punn A; Chen J; Randeva HS
    Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
    Kogan EA; Tyong FV; Demura SA
    Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
    Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.